441 related articles for article (PubMed ID: 18507839)
1. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.
Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS
J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.
Zhang F; Shi JS; Zhou H; Wilson B; Hong JS; Gao HM
Mol Pharmacol; 2010 Sep; 78(3):466-77. PubMed ID: 20554604
[TBL] [Abstract][Full Text] [Related]
3. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
Jiang L; Wu X; Wang S; Chen SH; Zhou H; Wilson B; Jin CY; Lu RB; Xie K; Wang Q; Hong JS
J Neuroinflammation; 2016 May; 13(1):110. PubMed ID: 27184631
[TBL] [Abstract][Full Text] [Related]
4. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.
Qian L; Xu Z; Zhang W; Wilson B; Hong JS; Flood PM
J Neuroinflammation; 2007 Sep; 4():23. PubMed ID: 17880684
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
[TBL] [Abstract][Full Text] [Related]
6. 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
Zhang W; Qin L; Wang T; Wei SJ; Gao HM; Liu J; Wilson B; Liu B; Zhang W; Kim HC; Hong JS
FASEB J; 2005 Mar; 19(3):395-7. PubMed ID: 15596482
[TBL] [Abstract][Full Text] [Related]
7. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
[TBL] [Abstract][Full Text] [Related]
8. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
Liu Y; Qin L; Li G; Zhang W; An L; Liu B; Hong JS
J Pharmacol Exp Ther; 2003 Apr; 305(1):212-8. PubMed ID: 12649371
[TBL] [Abstract][Full Text] [Related]
9. Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia.
Qian L; Wei SJ; Zhang D; Hu X; Xu Z; Wilson B; El-Benna J; Hong JS; Flood PM
J Immunol; 2008 Jul; 181(1):660-8. PubMed ID: 18566433
[TBL] [Abstract][Full Text] [Related]
10. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons.
Gao HM; Liu B; Hong JS
J Neurosci; 2003 Jul; 23(15):6181-7. PubMed ID: 12867501
[TBL] [Abstract][Full Text] [Related]
11. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia.
Qin L; Liu Y; Wang T; Wei SJ; Block ML; Wilson B; Liu B; Hong JS
J Biol Chem; 2004 Jan; 279(2):1415-21. PubMed ID: 14578353
[TBL] [Abstract][Full Text] [Related]
12. Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation.
Hu X; Zhou H; Zhang D; Yang S; Qian L; Wu HM; Chen PS; Wilson B; Gao HM; Lu RB; Hong JS
J Neuroimmune Pharmacol; 2012 Mar; 7(1):187-201. PubMed ID: 21870076
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 protects lipopolysaccharide-induced neurotoxicity in primary midbrain cultures by inhibiting the function of NADPH oxidase.
Qian L; Block ML; Wei SJ; Lin CF; Reece J; Pang H; Wilson B; Hong JS; Flood PM
J Pharmacol Exp Ther; 2006 Oct; 319(1):44-52. PubMed ID: 16807359
[TBL] [Abstract][Full Text] [Related]
14. Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation.
Liu Y; Lo YC; Qian L; Crews FT; Wilson B; Chen HL; Wu HM; Chen SH; Wei K; Lu RB; Ali S; Hong JS
Neuropharmacology; 2011; 60(2-3):373-80. PubMed ID: 20950631
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation.
Chung YC; Kim SR; Park JY; Chung ES; Park KW; Won SY; Bok E; Jin M; Park ES; Yoon SH; Ko HW; Kim YS; Jin BK
Neuropharmacology; 2011 May; 60(6):963-74. PubMed ID: 21288472
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological study of the novel compound FLZ against experimental Parkinson's models and its active mechanism.
Feng W; Wei H; Liu GT
Mol Neurobiol; 2005; 31(1-3):295-300. PubMed ID: 15953829
[TBL] [Abstract][Full Text] [Related]
17. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D
Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139
[TBL] [Abstract][Full Text] [Related]
18. Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
Li Y; Hu X; Liu Y; Bao Y; An L
Neuropharmacology; 2009 Mar; 56(3):580-9. PubMed ID: 19049811
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.
Moon M; Kim HG; Hwang L; Seo JH; Kim S; Hwang S; Kim S; Lee D; Chung H; Oh MS; Lee KT; Park S
Neurotox Res; 2009 May; 15(4):332-47. PubMed ID: 19384567
[TBL] [Abstract][Full Text] [Related]
20. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species.
Qin L; Liu Y; Cooper C; Liu B; Wilson B; Hong JS
J Neurochem; 2002 Nov; 83(4):973-83. PubMed ID: 12421370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
